文献速递血栓与止血

细菌蛋白酶IdeS切割抗PF4/肝素IgG及其在肝素诱导血小板减少症中的潜在获益

Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
PubMed 文献 · Blood · 2019-03-27

研究评估细菌蛋白酶IdeS切割抗PF4/肝素IgG能否抑制HIT抗体致病性。IdeS快速切割单克隆抗体5B9形成sc5B9,不降低与PF4/肝素复合物结合力,但大幅降低对血小板FcγRIIA亲和力,使其无法诱导肝素依赖性血小板活化。在含5B9或HIT血浆的全血中,IdeS切割抗PF4/肝素抗体,完全消除诱导血小板聚集和单核细胞组织因子mRNA合成的能力;在微流控通道中IdeS处理后5B9加肝素诱导的血小板聚集和纤维蛋白形成强烈减少;在表达人PF4和FcγRIIA受体的转基因小鼠中,IdeS预防5B9加肝素诱导的血小板减少和高凝状态。

要点

  • IdeS切割抗PF4/肝素IgG的铰链区,形成sc5B9,不降低与PF4/肝素复合物的结合力。
  • sc5B9对血小板FcγRIIA亲和力大幅降低,无法诱导肝素依赖性血小板活化。
  • IdeS在含HIT血浆全血中消除血小板聚集和单核细胞组织因子mRNA合成。

核心结论

  • IdeS切割抗PF4/肝素IgG可消除HIT抗体诱导的肝素依赖性细胞活化。
  • IdeS注射可能是严重HIT患者的潜在治疗方法。

研究设计与样本

  • 体外研究:使用纯化单克隆嵌合抗PF4/肝素IgG1抗体5B9、含5B9或HIT血浆的全血、von Willebrand因子包被的微流控通道全血灌注。
  • 动物实验:表达人PF4和FcγRIIA受体的转基因小鼠。

主要发现

  • IdeS快速切割纯化5B9形成单切割5B9(sc5B9),与未切割5B9相比,sc5B9对血小板FcγRIIA亲和力大幅降低,且不能诱导肝素依赖性血小板活化。
  • 在含5B9或HIT血浆的全血中孵育IdeS导致抗PF4/肝素抗体切割,完全消除诱导肝素依赖性血小板聚集和单核细胞组织因子mRNA合成的能力。
  • 在von Willebrand因子包被的微流控通道中灌注全血时,IdeS处理后5B9加肝素诱导的血小板聚集和纤维蛋白形成强烈减少。
  • 在表达人PF4和FcγRIIA受体的转基因小鼠中,IdeS预防5B9加肝素诱导的血小板减少和高凝状态。

临床怎么用

  • 原文结论认为IdeS注射可能是严重HIT患者的潜在治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is due to immunoglobulin G (IgG) antibodies, which bind platelet factor 4 (PF4) modified by polyanions, such as heparin (H). IgG/PF4/polyanion complexes directly activate platelets via Fc gamma type 2 receptor A (FcγRIIA) receptors. A bacterial protease, IgG-degrading enzyme of Streptococcus pyogenes (IdeS), cleaves the hinge region of heavy-chain IgG, abolishing its ability to bind FcγR, including FcγRIIA. We evaluated whether cleavage of anti-PF4/H IgG by IdeS could suppress the pathogenicity of HIT antibodies. IdeS quickly cleaved purified 5B9, a monoclonal chimeric anti-PF4/H IgG1, which led to the formation of single cleaved 5B9 (sc5B9), without any reduction in binding ability to the PF4/H complex. However, as compared with uncleaved 5B9, the affinity of sc5B9 for platelet FcγRIIA was greatly reduced, and sc5B9 was also unable to induce heparin-dependent platelet activation. In addition, incubating IdeS in whole blood containing 5B9 or HIT plasma samples led to cleavage of anti-PF4/H antibodies, which fully abolished the ability to induce heparin-dependent platelet aggregation and tissue factor messenger RNA synthesis by monocytes. Also, when whole blood was perfused in von Willebrand factor-coated microfluidic channels, platelet aggregation and fibrin formation induced by 5B9 with heparin was strongly reduced after IdeS treatment. Finally, IdeS prevented thrombocytopenia and hypercoagulability induced by 5B9 with heparin in transgenic mice expressing human PF4 and FcγRIIA receptors. In conclusion, cleavage of anti-PF4/H IgG by IdeS abolishes heparin-dependent cellular activation induced by HIT antibodies. IdeS injection could be a potential treatment of patients with severe HIT.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kizlik-Masson C, Deveuve Q, Zhou Y, et al. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia. Blood. 2019. PMID: 30917957. doi:10.1182/blood.2019000437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。